Profile data is unavailable for this security.
About the company
ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.
- Revenue in USD (TTM)8.19bn
- Net income in USD758.19m
- Incorporated1989
- Employees41.25k
- LocationICON PLCSouth County Business ParkLEOPARDSTOWN, Dublin 18DUBLIN 00000IrelandIRL
- Phone+353 12912000
- Fax+353 12912700
- Websitehttps://www.iconplc.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revolution Medicines Inc | 0.00 | -697.51m | 6.88bn | 616.00 | -- | 3.31 | -- | -- | -3.99 | -3.99 | 0.00 | 11.16 | 0.00 | -- | -- | 0.00 | -32.64 | -28.38 | -34.69 | -30.68 | -- | -- | -- | -1,324.37 | -- | -- | 0.00 | -- | -100.00 | -- | -37.52 | -- | 31.83 | -- |
| Charles River Lbrtrs ntrntl Inc | 4.02bn | -31.56m | 7.37bn | 18.60k | -- | 2.31 | 19.73 | 1.83 | -0.65 | -0.65 | 78.33 | 65.04 | 0.5113 | 8.07 | 5.21 | 216,268.70 | -0.2963 | 5.12 | -0.3424 | 6.01 | 34.69 | 36.56 | -0.5796 | 9.47 | 1.16 | 3.81 | 0.4368 | 0.00 | -1.92 | 9.09 | -97.83 | -47.25 | 10.64 | -- |
| BIO-TECHNE Corp | 1.21bn | 131.65m | 8.13bn | 3.10k | 63.19 | 4.03 | 33.51 | 6.72 | 0.8204 | 0.8204 | 7.54 | 12.87 | 0.4506 | 2.19 | 5.20 | 389,925.50 | 4.91 | 9.42 | 5.22 | 10.04 | 66.39 | 67.29 | 10.89 | 21.41 | 2.58 | 46.27 | 0.1405 | 22.79 | 1.97 | 10.17 | -41.07 | 11.86 | 19.87 | 0.00 |
| Blueprint Medicines Corp | 562.12m | -155.73m | 8.28bn | 682.00 | -- | 24.18 | -- | 14.74 | -2.46 | -2.46 | 8.77 | 5.30 | 0.5032 | 0.901 | 8.04 | 866,132.50 | -13.94 | -23.15 | -17.53 | -26.82 | 96.48 | 96.65 | -27.70 | -75.50 | 2.75 | -- | 0.5313 | -- | 104.04 | 50.22 | 86.77 | -- | -19.87 | -- |
| Regencell Bioscience Holdings Ltd | 0.00 | -4.30m | 8.60bn | 12.00 | -- | 1,046.73 | -- | -- | -0.0087 | -0.0087 | 0.00 | 0.0166 | 0.00 | -- | -- | 0.00 | -41.44 | -56.31 | -42.99 | -77.51 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 26.73 | -- | -- | -- |
| Medpace Holdings Inc | 2.16bn | 416.39m | 8.93bn | 5.90k | 23.71 | 15.58 | 20.04 | 4.14 | 13.10 | 13.10 | 67.79 | 19.94 | 1.17 | -- | 7.47 | 365,522.00 | 22.55 | 16.40 | 51.59 | 29.77 | 31.51 | 29.51 | 19.31 | 16.75 | -- | -- | 0.00 | 0.00 | 11.84 | 19.62 | 43.07 | 32.19 | 15.33 | -- |
| Exact Sciences Corp | 2.83bn | -1.02bn | 10.12bn | 6.90k | -- | 4.22 | -- | 3.58 | -5.50 | -5.50 | 15.26 | 12.71 | 0.468 | 5.74 | 10.87 | 409,873.60 | -16.87 | -11.29 | -18.71 | -12.38 | 69.02 | 71.21 | -36.06 | -30.90 | 2.38 | -173.16 | 0.494 | -- | 10.37 | 25.78 | -403.97 | -- | 0.9474 | -- |
| Moderna Inc | 3.18bn | -3.36bn | 10.50bn | 5.80k | -- | 1.04 | -- | 3.31 | -8.71 | -8.71 | 8.17 | 26.01 | 0.2159 | 4.70 | 29.55 | 547,758.60 | -22.81 | 13.72 | -26.38 | 18.76 | 68.68 | 76.34 | -105.67 | 23.74 | 4.14 | -- | 0.0062 | 0.00 | -52.75 | 121.86 | 24.46 | -- | 101.61 | -- |
| ICON PLC | 8.19bn | 758.19m | 11.49bn | 41.25k | 15.73 | 1.21 | 9.63 | 1.40 | 9.19 | 9.19 | 99.32 | 119.56 | 0.4852 | -- | 3.01 | 195,528.00 | 4.49 | 3.70 | 5.39 | 4.46 | 29.08 | 29.00 | 9.25 | 7.41 | -- | 5.82 | 0.2647 | -- | 1.99 | 24.17 | 29.26 | 16.18 | 27.11 | -- |
| Tempus AI Inc | 803.32m | -721.31m | 11.52bn | 2.40k | -- | 35.29 | -- | 14.34 | -7.79 | -7.79 | 5.49 | 1.89 | 0.7984 | 8.55 | 4.34 | 334,714.60 | -70.47 | -53.69 | -96.71 | -72.10 | 57.09 | 45.68 | -88.27 | -84.29 | 1.56 | -13.53 | 0.7106 | -- | 30.38 | 62.05 | -180.61 | -- | 5.36 | -- |
| Exelixis Inc | 2.30bn | 643.57m | 11.91bn | 1.15k | 19.81 | 5.64 | 17.69 | 5.18 | 2.20 | 2.20 | 7.88 | 7.75 | 0.8151 | 3.23 | 8.80 | 2,004,291.00 | 22.82 | 9.51 | 26.44 | 10.77 | 96.78 | 96.32 | 27.99 | 15.61 | 3.44 | -- | 0.00 | 0.00 | 18.49 | 17.51 | 150.89 | 10.18 | 17.25 | -- |
| Summit Therapeutics Inc | 0.00 | -240.76m | 15.30bn | 159.00 | -- | 44.37 | -- | -- | -0.3309 | -0.3309 | 0.00 | 0.4643 | 0.00 | -- | -- | 0.00 | -85.89 | -78.31 | -95.86 | -86.84 | -- | -- | -- | -31,307.77 | -- | -- | 0.00 | -- | -- | -- | 64.01 | -- | -16.43 | -- |
Data as of Jun 30 2025. Currency figures normalised to ICON PLC's reporting currency: US Dollar USD
34.82%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| WCM Investment Management LLCas of 31 Mar 2025 | 6.39m | 7.91% |
| Artisan Partners LPas of 31 Mar 2025 | 4.29m | 5.31% |
| Ninety One UK Ltd.as of 31 Mar 2025 | 2.92m | 3.61% |
| Wellington Management Co. LLPas of 31 Mar 2025 | 2.69m | 3.33% |
| Invesco Advisers, Inc.as of 31 Mar 2025 | 2.48m | 3.07% |
| Massachusetts Financial Services Co.as of 31 Mar 2025 | 2.28m | 2.83% |
| AllianceBernstein LPas of 31 Mar 2025 | 1.86m | 2.30% |
| ClearBridge Investments LLCas of 31 Mar 2025 | 1.84m | 2.28% |
| Templeton Global Advisors Ltd.as of 31 Mar 2025 | 1.70m | 2.10% |
| D. E. Shaw & Co. LPas of 31 Mar 2025 | 1.66m | 2.06% |
More ▼
Data from 31 Mar 2025 - 31 Mar 2025Source: FactSet Research Systems Inc.
